MarketPulse

Phase 2 results

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

ImmunityBio Faces Class Action After Failed Trial Triggers 12% Stock Plunge

Portnoy Law Firm launches class action against $IMNB following failed Phase 2 glioblastoma trial, citing investor losses from steep stock decline.
IBRXclass action lawsuitinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Arcutis to Report Q1 2026 Results as Clinical Data Advances Dermatology Pipeline

Arcutis reports Q1 2026 results May 6 as company presents new Phase 2 pediatric atopic dermatitis data at dermatology conference.
ARQTfinancial resultsclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Zealand Pharma

Zealand Pharma's Petrelintide Shows Promise in Obesity Drug Race

Zealand Pharma reports positive Phase 2 data for petrelintide, achieving 10.7% weight loss versus 1.7% placebo with favorable safety profile.
RHHBYZLDPYobesityweight management